Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation

Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Poly...

Full description

Saved in:
Bibliographic Details
Published inDrug metabolism and pharmacokinetics Vol. 30; no. 1; pp. 119 - 122
Main Authors Saito, Takahiro, Honda, Masashi, Takahashi, Masamitsu, Tsukada, Chiharu, Ito, Miyabi, Katono, Yuki, Hosono, Hiroki, Saigusa, Daisuke, Suzuki, Naoto, Tomioka, Yoshihisa, Hirasawa, Noriyasu, Hiratsuka, Masahiro
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.
AbstractList Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.
Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.
Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid. CYP4A11 metabolizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), which is important for the regulation of blood pressure. Polymorphisms in CYP4A11 are associated with susceptibility to hypertension. In this study, we evaluated the in vitro ω-hydroxylation of arachidonic acid by 10 CYP4A11 allelic variants, which cause amino acid substitutions in the encoded proteins. CYP4A11 variants were heterologously expressed in COS-7 cells and the kinetic parameters of arachidonic acid ω-hydroxylation were estimated. Among 10 CYP4A11 variants, 5 (CYP4A11-v1, CYP4A11-v2, CYP4A11-v3, CYP4A11-v4, and CYP4A11-v7) showed no or markedly lower activity compared to wild-type CYP4A11. This functional analysis of CYP4A11 variants could provide useful information for the effective prevention and treatment of hypertension.
Author Tsukada, Chiharu
Hosono, Hiroki
Saito, Takahiro
Ito, Miyabi
Honda, Masashi
Takahashi, Masamitsu
Hiratsuka, Masahiro
Katono, Yuki
Suzuki, Naoto
Hirasawa, Noriyasu
Saigusa, Daisuke
Tomioka, Yoshihisa
Author_xml – sequence: 1
  givenname: Takahiro
  surname: Saito
  fullname: Saito, Takahiro
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 2
  givenname: Masashi
  surname: Honda
  fullname: Honda, Masashi
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 3
  givenname: Masamitsu
  surname: Takahashi
  fullname: Takahashi, Masamitsu
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 4
  givenname: Chiharu
  surname: Tsukada
  fullname: Tsukada, Chiharu
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 5
  givenname: Miyabi
  surname: Ito
  fullname: Ito, Miyabi
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 6
  givenname: Yuki
  surname: Katono
  fullname: Katono, Yuki
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 7
  givenname: Hiroki
  surname: Hosono
  fullname: Hosono, Hiroki
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 8
  givenname: Daisuke
  surname: Saigusa
  fullname: Saigusa, Daisuke
  organization: Department of Integrative Genomics, Tohoku Medical Megabank, Tohoku University, Sendai, Japan
– sequence: 9
  givenname: Naoto
  surname: Suzuki
  fullname: Suzuki, Naoto
  organization: Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 10
  givenname: Yoshihisa
  surname: Tomioka
  fullname: Tomioka, Yoshihisa
  organization: Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 11
  givenname: Noriyasu
  surname: Hirasawa
  fullname: Hirasawa, Noriyasu
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
– sequence: 12
  givenname: Masahiro
  surname: Hiratsuka
  fullname: Hiratsuka, Masahiro
  email: mhira@m.tohoku.ac.jp
  organization: Laboratory of Pharmacotherapy of Life-Style Related Disease, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25760539$$D View this record in MEDLINE/PubMed
BookMark eNp9kb1uFDEUhS0URH7gBSiQS5oZ7PGMdyzRRKsEkCJBAQWVdce-w3rxjhfbu2Ip6fJ0eSU82UBBkepaV-c7Vz7nnJxMYUJCXnJWc8blm3VtN9vvdcN4WzNVM8afkDPe96xiqmEn5S3aRdUKuTgl5ymtGROia5tn5LTpFpJ1Qp2R39e7yWQXJvDUrCCCyRjdL5hXNIyUM7r8-qm95JyC9-idoXuIDqacaA4U9-B3kJHmFVIcRzR5pr7hFPJhi7SYzJ4rZ8NUUDDO0rvbanWwMfw8-Pszz8nTEXzCFw_zgny5vvq8fF_dfHz3YXl5UxnRs1x1rOHdKAZopJWco7KsF73teiEHGDiHBYdGmQEAhVGmDK5kr8qXhek6q8QFeX303cbwY4cp641LBr2HCcMuaS6lkJ1s1Sx99SDdDRu0ehvdBuJB_82tCJqjwMSQUsTxn4QzPZej13ouR8_laKZ0KadA_X-Qcfk-ghzB-cfRt0cUS0B7h1En43AyaF0smWsb3GP4H86Yq6k
CitedBy_id crossref_primary_10_1016_j_dmpk_2016_09_003
crossref_primary_10_1016_j_cbi_2023_110644
crossref_primary_10_3390_ijms20184500
crossref_primary_10_62347_VLGD3371
crossref_primary_10_1016_j_heliyon_2023_e21308
crossref_primary_10_1124_dmd_123_001389
crossref_primary_10_1016_j_forsciint_2020_110293
crossref_primary_10_1124_jpet_118_249557
Cites_doi 10.1038/314620a0
10.1161/HYPERTENSIONAHA.108.114082
10.1016/j.gene.2012.10.007
10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D
10.1016/S0022-3565(24)37530-5
10.1681/ASN.2008010063
10.1111/j.1601-5223.2012.02247.x
10.1016/j.gene.2011.07.015
10.1161/01.HYP.13.5_Suppl.I13
10.1038/10297
10.1161/01.RES.72.1.126
10.1161/01.HYP.0000182658.04299.15
10.1097/HJH.0b013e32834aa786
10.1161/01.CIR.0000151309.82473.59
10.1172/JCI119279
10.1177/1076029611436197
10.1097/HJH.0b013e3282f2f10c
10.1007/s11886-006-0098-7
ContentType Journal Article
Copyright 2014 The Japanese Society for the Study of Xenobiotics
Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2014 The Japanese Society for the Study of Xenobiotics
– notice: Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.dmpk.2014.09.001
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1880-0920
EndPage 122
ExternalDocumentID 25760539
10_1016_j_dmpk_2014_09_001
S1347436714000020
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--M
0R~
29G
2WC
4.4
457
53G
5GY
7-5
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXUO
ABJNI
ABMAC
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BAWUL
BKOJK
BKOMP
BLXMC
CS3
DIK
DU5
E3Z
EBS
EFJIC
EFLBG
EJD
F5P
FDB
FEDTE
FIRID
FYGXN
GBLVA
GX1
HH5
HVGLF
HZ~
JMI
JSF
JSH
KOM
KQ8
M41
MOJWN
M~E
O9-
OAUVE
RJT
RNS
ROL
RZJ
SPCBC
SSP
SSZ
T5K
TKC
TR2
~G-
AAQFI
AATTM
AAXKI
AAYWO
AAYXX
ACVFH
ADCNI
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
OVT
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
ID FETCH-LOGICAL-c380t-50215f3ba26d611e9d0838d5836bab11a71a29cbaae3c9caae196893353c55d93
IEDL.DBID AIKHN
ISSN 1347-4367
1880-0920
IngestDate Fri Jul 11 07:24:27 EDT 2025
Mon Jul 21 06:01:22 EDT 2025
Tue Jul 01 05:05:44 EDT 2025
Thu Apr 24 22:58:36 EDT 2025
Fri Feb 23 02:32:23 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Hypertension
20-HETE
Arachidonic acid
Cytochrome P450
Genetic polymorphisms
CYP4A11
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2014 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c380t-50215f3ba26d611e9d0838d5836bab11a71a29cbaae3c9caae196893353c55d93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25760539
PQID 1663656499
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_1663656499
pubmed_primary_25760539
crossref_primary_10_1016_j_dmpk_2014_09_001
crossref_citationtrail_10_1016_j_dmpk_2014_09_001
elsevier_sciencedirect_doi_10_1016_j_dmpk_2014_09_001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-02-01
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Drug metabolism and pharmacokinetics
PublicationTitleAlternate Drug Metab Pharmacokinet
PublicationYear 2015
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Barri (bib2) 2006; 8
Ma, Gebremedhin, Schwartzman, Falck, Clark, Masters (bib5) 1993; 72
Halushka, Fan, Bentley, Hsie, Shen, Weder (bib3) 1999; 22
Sugimoto, Akasaka, Katsuya, Node, Fujisawa, Shimaoka (bib8) 2008; 52
Williams, Hopkins, Jeunemaitre, Brown (bib15) 2011; 29
Nowicki, Chen, Aizman, Cheng, Li, Nowicki (bib7) 1997; 99
Fu, Yang, Ma, Huang, Xie, Zheng (bib10) 2013; 512
Fu, Ma, Xie, Huang, Yang, Nakayama (bib9) 2013; 19
Powell, Wolf, Jin, Lasker (bib16) 1998; 285
Chang, Loew (bib17) 1999; 34
Stokes, Kannel, Wolf, D'Agostino, Cupples (bib1) 1989; 13
Fu, Nakayama, Sato, Izumi, Kasamaki, Shindo (bib14) 2008; 26
Gainer, Lipkowitz, Yu, Waterman, Dawson, Capdevila (bib20) 2008; 19
Lino Cardenas, Renault, Farce, Cauffiez, Allorge, Lo-Guidice (bib18) 2011; 487
(bib19) 1993
Schwartzman, Ferreri, Carroll, Songu-Mize, McGiff (bib6) 1985; 314
Fu, Nakayama, Sato, Izumi, Kasamaki, Shindo (bib11) 2012; 149
Mayer, Lieb, Gotz, Konig, Aherrahrou, Thiemig (bib13) 2005; 46
Zou, Fleming, Falck, Jacobs, Gebremedhin, Harder (bib4) 1996; 270
Gainer, Bellamine, Dawson, Womble, Grant, Wang (bib12) 2005; 111
Ma (10.1016/j.dmpk.2014.09.001_bib5) 1993; 72
Zou (10.1016/j.dmpk.2014.09.001_bib4) 1996; 270
(10.1016/j.dmpk.2014.09.001_bib19) 1993
Gainer (10.1016/j.dmpk.2014.09.001_bib12) 2005; 111
Mayer (10.1016/j.dmpk.2014.09.001_bib13) 2005; 46
Sugimoto (10.1016/j.dmpk.2014.09.001_bib8) 2008; 52
Lino Cardenas (10.1016/j.dmpk.2014.09.001_bib18) 2011; 487
Fu (10.1016/j.dmpk.2014.09.001_bib11) 2012; 149
Williams (10.1016/j.dmpk.2014.09.001_bib15) 2011; 29
Powell (10.1016/j.dmpk.2014.09.001_bib16) 1998; 285
Schwartzman (10.1016/j.dmpk.2014.09.001_bib6) 1985; 314
Fu (10.1016/j.dmpk.2014.09.001_bib14) 2008; 26
Fu (10.1016/j.dmpk.2014.09.001_bib9) 2013; 19
Fu (10.1016/j.dmpk.2014.09.001_bib10) 2013; 512
Barri (10.1016/j.dmpk.2014.09.001_bib2) 2006; 8
Gainer (10.1016/j.dmpk.2014.09.001_bib20) 2008; 19
Stokes (10.1016/j.dmpk.2014.09.001_bib1) 1989; 13
Nowicki (10.1016/j.dmpk.2014.09.001_bib7) 1997; 99
Chang (10.1016/j.dmpk.2014.09.001_bib17) 1999; 34
Halushka (10.1016/j.dmpk.2014.09.001_bib3) 1999; 22
References_xml – volume: 22
  start-page: 239
  year: 1999
  end-page: 247
  ident: bib3
  article-title: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
  publication-title: Nat Genet
– volume: 13
  start-page: I13
  year: 1989
  end-page: I18
  ident: bib1
  article-title: Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up
  publication-title: Hypertension
– volume: 270
  start-page: R228
  year: 1996
  end-page: R237
  ident: bib4
  article-title: 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles
  publication-title: Am J Physiol
– volume: 512
  start-page: 510
  year: 2013
  end-page: 516
  ident: bib10
  article-title: Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China
  publication-title: Gene
– volume: 314
  start-page: 620
  year: 1985
  end-page: 622
  ident: bib6
  article-title: Renal cytochrome P450-related arachidonate metabolite inhibits (Na
  publication-title: Nature
– year: 1993
  ident: bib19
  publication-title: Cytochrome P-450
– volume: 29
  start-page: 1913
  year: 2011
  end-page: 1918
  ident: bib15
  article-title: CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow
  publication-title: J Hypertens
– volume: 487
  start-page: 10
  year: 2011
  end-page: 20
  ident: bib18
  article-title: Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population
  publication-title: Gene
– volume: 99
  start-page: 1224
  year: 1997
  end-page: 1230
  ident: bib7
  article-title: 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na
  publication-title: J Clin Invest
– volume: 46
  start-page: 766
  year: 2005
  end-page: 771
  ident: bib13
  article-title: Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy
  publication-title: Hypertension
– volume: 34
  start-page: 403
  year: 1999
  end-page: 415
  ident: bib17
  article-title: Homology modeling and substrate binding study of human CYP4A11 enzyme
  publication-title: Proteins
– volume: 72
  start-page: 126
  year: 1993
  end-page: 136
  ident: bib5
  article-title: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries
  publication-title: Circ Res
– volume: 285
  start-page: 1327
  year: 1998
  end-page: 1336
  ident: bib16
  article-title: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11
  publication-title: J Pharmacol Exp Ther
– volume: 52
  start-page: 1142
  year: 2008
  end-page: 1148
  ident: bib8
  article-title: A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population
  publication-title: Hypertension
– volume: 8
  start-page: 411
  year: 2006
  end-page: 417
  ident: bib2
  article-title: Hypertension and kidney disease: a deadly connection
  publication-title: Curr Cardiol Rep
– volume: 149
  start-page: 91
  year: 2012
  end-page: 98
  ident: bib11
  article-title: Haplotype-based case-control study of CYP4A11 gene and myocardial infarction
  publication-title: Hereditas
– volume: 26
  start-page: 453
  year: 2008
  end-page: 461
  ident: bib14
  article-title: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men
  publication-title: J Hypertens
– volume: 111
  start-page: 63
  year: 2005
  end-page: 69
  ident: bib12
  article-title: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension
  publication-title: Circulation
– volume: 19
  start-page: 1606
  year: 2008
  end-page: 1612
  ident: bib20
  article-title: Association of a CYP4A11 variant and blood pressure in black men
  publication-title: J Am Soc Nephrol
– volume: 19
  start-page: 60
  year: 2013
  end-page: 65
  ident: bib9
  article-title: A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease
  publication-title: Clin Appl Thromb Hemost
– volume: 314
  start-page: 620
  year: 1985
  ident: 10.1016/j.dmpk.2014.09.001_bib6
  article-title: Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase
  publication-title: Nature
  doi: 10.1038/314620a0
– volume: 52
  start-page: 1142
  year: 2008
  ident: 10.1016/j.dmpk.2014.09.001_bib8
  article-title: A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese population
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.108.114082
– volume: 512
  start-page: 510
  year: 2013
  ident: 10.1016/j.dmpk.2014.09.001_bib10
  article-title: Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China
  publication-title: Gene
  doi: 10.1016/j.gene.2012.10.007
– volume: 270
  start-page: R228
  year: 1996
  ident: 10.1016/j.dmpk.2014.09.001_bib4
  article-title: 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles
  publication-title: Am J Physiol
– volume: 34
  start-page: 403
  year: 1999
  ident: 10.1016/j.dmpk.2014.09.001_bib17
  article-title: Homology modeling and substrate binding study of human CYP4A11 enzyme
  publication-title: Proteins
  doi: 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D
– volume: 285
  start-page: 1327
  year: 1998
  ident: 10.1016/j.dmpk.2014.09.001_bib16
  article-title: Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)37530-5
– volume: 19
  start-page: 1606
  year: 2008
  ident: 10.1016/j.dmpk.2014.09.001_bib20
  article-title: Association of a CYP4A11 variant and blood pressure in black men
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008010063
– volume: 149
  start-page: 91
  year: 2012
  ident: 10.1016/j.dmpk.2014.09.001_bib11
  article-title: Haplotype-based case-control study of CYP4A11 gene and myocardial infarction
  publication-title: Hereditas
  doi: 10.1111/j.1601-5223.2012.02247.x
– volume: 487
  start-page: 10
  year: 2011
  ident: 10.1016/j.dmpk.2014.09.001_bib18
  article-title: Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population
  publication-title: Gene
  doi: 10.1016/j.gene.2011.07.015
– volume: 13
  start-page: I13
  year: 1989
  ident: 10.1016/j.dmpk.2014.09.001_bib1
  article-title: Blood pressure as a risk factor for cardiovascular disease. The Framingham Study–30 years of follow-up
  publication-title: Hypertension
  doi: 10.1161/01.HYP.13.5_Suppl.I13
– volume: 22
  start-page: 239
  year: 1999
  ident: 10.1016/j.dmpk.2014.09.001_bib3
  article-title: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
  publication-title: Nat Genet
  doi: 10.1038/10297
– volume: 72
  start-page: 126
  year: 1993
  ident: 10.1016/j.dmpk.2014.09.001_bib5
  article-title: 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries
  publication-title: Circ Res
  doi: 10.1161/01.RES.72.1.126
– volume: 46
  start-page: 766
  year: 2005
  ident: 10.1016/j.dmpk.2014.09.001_bib13
  article-title: Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000182658.04299.15
– volume: 29
  start-page: 1913
  year: 2011
  ident: 10.1016/j.dmpk.2014.09.001_bib15
  article-title: CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e32834aa786
– volume: 111
  start-page: 63
  year: 2005
  ident: 10.1016/j.dmpk.2014.09.001_bib12
  article-title: Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000151309.82473.59
– year: 1993
  ident: 10.1016/j.dmpk.2014.09.001_bib19
– volume: 99
  start-page: 1224
  year: 1997
  ident: 10.1016/j.dmpk.2014.09.001_bib7
  article-title: 20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase
  publication-title: J Clin Invest
  doi: 10.1172/JCI119279
– volume: 19
  start-page: 60
  year: 2013
  ident: 10.1016/j.dmpk.2014.09.001_bib9
  article-title: A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease
  publication-title: Clin Appl Thromb Hemost
  doi: 10.1177/1076029611436197
– volume: 26
  start-page: 453
  year: 2008
  ident: 10.1016/j.dmpk.2014.09.001_bib14
  article-title: A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men
  publication-title: J Hypertens
  doi: 10.1097/HJH.0b013e3282f2f10c
– volume: 8
  start-page: 411
  year: 2006
  ident: 10.1016/j.dmpk.2014.09.001_bib2
  article-title: Hypertension and kidney disease: a deadly connection
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-006-0098-7
SSID ssj0033542
Score 2.0825913
Snippet Genetic variations in cytochrome P450 4A11 (CYP4A11) contributes to inter-individual variability in the metabolism of fatty acids such as arachidonic acid....
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 119
SubjectTerms 20-HETE
Alleles
Animals
Arachidonic acid
Arachidonic Acid - metabolism
Cercopithecus aethiops
COS Cells
CYP4A11
Cytochrome P-450 CYP4A
Cytochrome P-450 Enzyme System - genetics
Cytochrome P-450 Enzyme System - metabolism
Cytochrome P450
Genetic polymorphisms
Genotype
Humans
Hydroxylation
Hypertension
Mutagenesis, Site-Directed
Polymorphism, Single Nucleotide
Transfection
Title Functional characterization of 10 CYP4A11 allelic variants to evaluate the effect of genotype on arachidonic acid ω-hydroxylation
URI https://dx.doi.org/10.1016/j.dmpk.2014.09.001
https://www.ncbi.nlm.nih.gov/pubmed/25760539
https://www.proquest.com/docview/1663656499
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEB216YUL4ptAqRYJ9UKteLNeZ32MIkIAUUWilcJptV9WDSWJaIqUa2_8uv6lzmTXqZCgB06WrV3b2h3PvF2_eQPwZuBVXQqDxhv6dYYRImTWBJmZ3PqBLYjaQInCn4_LyWnxcSZnOzBqc2GIVpl8f_TpG2-drvTSaPaWTdP7QkmQhShJcW7zQ20X9voYXfMO7A0_fJoctw5ZCLmpoUPtM-qQcmcizcv_WH4nhleUO021Yf4Sn_6FPzdxaPwA7icAyYbxHR_CTpg_gsNpVKBeH7GT24SqiyN2yKa32tTrx3A1xjgWt_-Y22o1x1RMtqgZz9no67QYcs6oyMp549gvXE0TWYatFixpgweGsJFFKgj1IqFX2stleBO651njSXGXGdd4dv07O1t7YstE2t0TOB2_OxlNslSGIXNC5atMEiyohTX90pech8ojbFNeKlFaYzk3A276lbPGBOEqhwf8qhEGCSmclL4ST6EzX8zDc2DSqBo9Gs99XZK2mOK58oUXSpVK2arsAm8HX7ukUU6lMs51S0b7pmnCNE2Yziti5HXh7bbPMip03NlatnOq_7AzjSHkzn6vWwPQ-AHSXxUzD4vLC80RsyEoxpVjF55Fy9i-B63m0MtVL_7zqS_hHp7JyBLfh87q52V4hSBoZQ-SkR_A7vsZvwG-wQam
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NjtMwELZWuwe4IP4pv4MEe2GjxkmcOgcO1ULV0t2qEl1pORnHdrRZlraiXVCv3HgeHoRXYqZ2ukKCPSDtKVJiO5ZnPDNOvvmGsRcdK6s81ai8Lqki9BAuKrUTkY5L2ykzgjZQovDhKO8fZe-OxfEW-9nkwhCsMth-b9PX1jrcaYfVbM_ruv2ekiCzNCfGufUPtYCsHLrVNzy3LV4P3qCQXyZJ7-1kvx-F0gKRSWW8jAS5uiotdZLbnHNXWAxFpBUyzUtdcq47XCeFKbV2qSkMXlBTqTK9SI0QlhiY0O7vEBsWbqud7mDYHzUOAButa_bQ_CKaYMjV8bAy-3n-iRBlnl411KL5iz_8V7y79nu9m-xGCFih69fkFtty09tsd-wZr1d7MLlI4FrswS6ML7iwV3fY9x76Tf-5EcyGG9qnfsKsAh7D_odx1uUcqKjLWW3gK57eCZwDyxkELnIHGKaCh55QLyKWpW_HgIPQmCe1JYZf0Ka28OtHdLKyhM7xML-77OhKZHOPbU9nU_eAgdCyQgvKY1vlxGUmeSxtZlMpcynLIm8x3iy-MoETnUpznKkG_HaqSGCKBKbighCALfZq02fuGUEubS0amao_9Fqhy7q03_NGARRuePqLo6dudr5QHGNEDMLxpNpi971mbOZBp0e0qsXD_3zrM3atPzk8UAeD0fARu45PhEeoP2bbyy_n7gkGYMvyaVB4YB-veo_9Bt0sQlw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+characterization+of+10+CYP4A11+allelic+variants+to+evaluate+the+effect+of+genotype+on+arachidonic+acid+%CF%89-hydroxylation&rft.jtitle=Drug+metabolism+and+pharmacokinetics&rft.au=Saito%2C+Takahiro&rft.au=Honda%2C+Masashi&rft.au=Takahashi%2C+Masamitsu&rft.au=Tsukada%2C+Chiharu&rft.date=2015-02-01&rft.eissn=1880-0920&rft.volume=30&rft.issue=1&rft.spage=119&rft_id=info:doi/10.1016%2Fj.dmpk.2014.09.001&rft_id=info%3Apmid%2F25760539&rft.externalDocID=25760539
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-4367&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-4367&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-4367&client=summon